The Impact of Systemic Light Chain Amyloidosis on Eyes and Its Appendages
Objective: To assess the involvement of the anterior segment of the eye, as well as the extraocular soft tissues and muscles, in patients with systemic light chain amyloidosis. Secondary Objective: To assess the neuro-ophthalmic manifestations and changes in retinal choroidal blood flow in patients with systemic light chain amyloidosis. Study
Design: Observational study. Study Population and Expected Enrollment: 80 patients with systemic light chain amyloidosis, 50 normal controls. Study Duration: Six months of follow-up after the last subject is diagnosed and enrolled. Intervention: Experimental Group: Patients with systemic light chain amyloidosis; Control Group: Subjects without systemic diseases.
• Patients diagnosed with Systemic Light Chain Amyloidosis;
• No other severe systemic underlying diseases that affect the examination;
• Subjects voluntarily participate in this study, sign the informed consent form;
• Age between 18-80 years old, no gender restrictions.
• Stable general condition, not patients with Systemic Light Chain Amyloidosis;
• No other severe systemic underlying diseases that affect the examination;
• Subjects voluntarily participate in this study, sign the informed consent form;
• Age between 18-80 years old, no gender restrictions.